593 F.3d 428 (5th Cir. 2010), 08-31204, Demahy v. Actavis, Inc.
Linked as:
Extract
593 F.3d 428 (5th Cir. 2010), 08-31204, Demahy v. Actavis, Inc.
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not described in section 201.56(b)(1)
- Code of Federal Regulations - Prescription-drug advertisements
- Code of Federal Regulations - Supplements and other changes to an approved NDA
- Code of Federal Regulations - Content and format of an abbreviated application
- Code of Federal Regulations - Supplements and other changes to an approved ANDA